8FY7

SARS-CoV-2 main protease in complex with covalent inhibitor

8FY7 の概要

• エントリーDOI: 10.2210/pdb8fy7/pdb
• 関連するPDBエントリー: 8FY6
• 分子名称: 3C-like proteinase nsp5, 4-methoxy-N-[(2S)-4-methyl-1-oxo-1-({(2S)-1-[(3S)-2-oxopyrrolidin-3-yl]but-3-en-2-yl}amino)pentan-2-yl]-1H-indole-2-carboxamide (3 entities in total)
• 機能のキーワード: sars-cov-2 main protease, protease, non-structural protein, covalent inhibitor, viral protein, hydrolase-inhibitor complex, hydrolase/inhibitor
• 由来する生物種: Severe acute respiratory syndrome coronavirus 2
• タンパク質・核酸の鎖数: 2
• 化学式量合計: 68532.16

構造登録者

Fried, W.,Chen, X.S. (登録日: 2023-01-25, 公開日: 2023-08-30, 最終更新日: 2023-09-27)

主引用文献

Ngo, C.,Fried, W.,Aliyari, S.,Feng, J.,Qin, C.,Zhang, S.,Yang, H.,Shanaa, J.,Feng, P.,Cheng, G.,Chen, X.S.,Zhang, C.
Alkyne as a Latent Warhead to Covalently Target SARS-CoV-2 Main Protease.
J.Med.Chem., 66:12237-12248, 2023

PubMed Abstract: There is an urgent need for improved therapy to better control the ongoing COVID-19 pandemic. The main protease M plays a pivotal role in SARS-CoV-2 replications, thereby representing an attractive target for antiviral development. We seek to identify novel electrophilic warheads for efficient, covalent inhibition of M. By comparing the efficacy of a panel of warheads installed on a common scaffold against M, we discovered that the terminal alkyne could covalently modify M as a latent warhead. Our biochemical and X-ray structural analyses revealed the irreversible formation of the vinyl-sulfide linkage between the alkyne and the catalytic cysteine of M. Clickable probes based on the alkyne inhibitors were developed to measure target engagement, drug residence time, and off-target effects. The best alkyne-containing inhibitors potently inhibited SARS-CoV-2 infection in cell infection models. Our findings highlight great potentials of alkyne as a latent warhead to target cystine proteases in viruses and beyond.

PubMed: 37595260
DOI: 10.1021/acs.jmedchem.3c00810

実験手法

X-RAY DIFFRACTION (1.94 Å)